Early signs remain encouraging for treating autism with bacterial pills
A novel approach to treating autism being developed through research and experimentation led by Fulton Schools Professors Rosa Krajmalnik-Brown and James Adams continues to draw widespread attention. Krajmalnik-Brown’s recent presentation at the annual meeting of the American Association for the Advancement of Science provided an update on the new method called microbiota transfer therapy, which involves altering bacteria in the gut to improve both digestive health and brain function in children with autism spectrum disorder. Results have shown the treatment led to a decrease in the gastrointestinal symptoms of autism in the children and to improvement in their behavior. Researchers hope further studies will reveal which microbes and the molecules they produce are most effective in improving the health of people with autism.